CVRx, Inc.
Longer-Term Clinical Trial Findings Show Significant Reduction in Blood Pressure, Improvement in Heart Function with CVRx® Rheos® System
Published in Medical Device Law Weekly, April 19th, 2009
CVRx announced that longer-term data from early Rheos clinical studies show significant reductions in hypertension and improvements in heart structure and function. The Rheos® Hypertension System, developed by the Minneapolis-based company, is the first device designed to treat hypertension, a leading cause of heart and kidney disease, stroke and death. The Rheos System activates the carotid baroreflex, the body’s own system for regulating blood pressure, and may provide a future treatment option for the millions of people who cannot control their high blood pressure (hypertension) with medications.
“We continue to see favorable clinical results that build on earlier...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Device Law Weekly
More Articles from Medical Device Law Weekly
- Ambulatory Surgery
Medical Web Technologies Enables Ambulatory Surgery Centers to Meet New CMS Regulatory Guidelines on Patient Rights - Cancer
New Tool in the Radiography Approach Will Assist in Earlier Detection of Asbestos-Related Diseases - Center for Justice & Democracy
Consumer Group Releases New Study About Defective Heart Devices and Implants; Patients Arrive in DC Tomorrow - HiFi DNA Tech
Recently Approved HPV Test May Prompt Unnecessary Surgical Biopsies on Women: HiFi DNA Seeks Transparency of “Results” from the FDA and Scientific Data on Newly Approved Human Papillomavirus HPV Tests - Life Sciences
Study findings on life sciences are outlined in reports from S.L. Camhi and colleagues - Patents
Appeals Court Affirms That J&J Stents Infringe Boston Scientific Patent; Claims Against TAXUS Liberte Dismissed - More from this issue of Medical Device Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
